3Malone JI,Morrison AD,Pavan PR. Prevalence and signifi-cance of retinopathy in subjects with type 1 diabetes of less than 5 years'duration screened for the diabetes control and complica-tions trial[J].{H}DIABETES CARE,2001,(3):522-526.
4Behr-Roussel D,Bernabe J,Compagnie S. Distinct mech-anisms implicated in atherosclerosis-induced erectile dysfunc-tion in rabbits[J].{H}ATHEROSCLEROSIS,2002,(2):355-362.
5Abdel-Hamid IA,Eraky I,Fouda MA. Role of penile vascular insufficiency in erectile dysfunction in renal transplant recipients[J].{H}International Journal of Impotence Research,2002,(1):32-37.
6Lorenazi M. Glucose toxicity in the vascular complications of di-abetes:the cellular perspective[J].{H}Diabetes Metabolism Reviews,1992,(2):85-103.
7Devara JS,Xu DY,Jialal I. C-reactive protein increases plas-minogen activator inhibitor-1 expression and activity in human aortic endothelial cells:implications for the metabolic syndrome and atherothrombosis[J].{H}CIRCULATION,2003,(3):398-404.
3Gasperini G, de Siqueira IC, Costa LR. Lower-level laser therapy improves neurosensory disorders resulting from bilateral mandibular sagittal split osteotomy: a randomized crossover clinical trial[J]. J Craniomaxillofac Surg, 2014, 42 ( 5 ) : e 130-e 133. DOI: 10.1016/j .j cms.2013.07.009.
4Tolonen N, Hietala K, Forsblom C, et al. Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the Finn Diane Study[J]. J Intern Med, 2013, 274(5) :469-479. DOI: 10.1111/ joim.12111.
